Osteoporosis. World Health Organisation

Similar documents
Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

John J. Wolf, DO Family Medicine

Nurse to Nurse Hospital or Hiking: You choose

Osteoporosis/Fracture Prevention

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

1

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

Osteoporosis Clinical Guideline. Rheumatology January 2017

This house believes that HRT should be the first-line prevention for postmenopausal osteoporosis: the case against

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Management of postmenopausal osteoporosis

Using the FRAX Tool. Osteoporosis Definition

Horizon Scanning Technology Briefing. Zoledronic Acid (Aclasta) once yearly treatment for postmenopausal. National Horizon Scanning Centre

Osteoporosis. Overview

Prevention Diagnosis Assessment Prescription and /or application of wide range of interventions and PRM program management

DISEASES AND DISORDERS

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Osteoporosis challenges

Page 1

Aromatase Inhibitors & Osteoporosis

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Building Bone Density-Research Issues

Summary. Background. Diagnosis

HORMONE THERAPY A BALANCED VIEW?? Prof Greta Dreyer

Osteoporosis. Treatment of a Silently Developing Disease

[If no, skip to question 10.] Y N. 2. Does the member have a diagnosis of Paget s disease of bone? Y N. [If no, skip to question 4.

3. Has bone specific alkaline phosphatase level increased OR does the member have symptoms related to active Paget s?

NEW DEVELOPMENTS IN OSTEOPOROSIS: SCREENING, PREVENTION AND TREATMENT

BREAST CANCER AND BONE HEALTH

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

Osteoarthritis. Dr Anthony Feher. With special thanks to Dr. Tim Williams and Dr. Bhatia for allowing me to use some of their slides

Bone density scanning and osteoporosis

Measuring Bone Mineral Density

Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women

Fracture Liaison Service and nhfd Local provision in London

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

Download slides:

Drug Intervals (Holidays) with Oral Bisphosphonates

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

NE Nebraska Trauma Conference Tristan Hartzell, MD November 8, 2017

Functional Well-Being. Neck, Shoulders and Wrist

Osteoporosis Screening and Treatment in Type 2 Diabetes

Prevention and Treatment of OSTEOPOROSIS 骨質疏鬆的預防與治療

Skeletal Manifestations

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Osteoarthritis of the neck

Referral Criteria: Carpal Tunnel Syndrome Feb

Facts About Aging and. Bone Health. A Guide to Better Understanding and Well-Being. This educational information is proudly provided by

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

Chapter 39: Exercise prescription in those with osteoporosis

Understanding NICE guidance. NICE technology appraisal guidance advises on when and how drugs and other treatments should be used in the NHS.

All about. Osteoporosis

The Bare Bones of Osteoporosis. Wendy Rosenthal, PharmD

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

An audit of osteoporotic patients in an Australian general practice

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status.

Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329

Initial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above

Page 1. Current and Emerging Strategies What s New in Osteoporosis. Osteoporosis. What is Osteoporosis? Traditional Risk Factors for Fracture

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck

Osteoporosis. Osteoporosis ADD PICTURE

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

New Developments in Osteoporosis: Screening, Prevention and Treatment

An Update on Osteoporosis Treatments

Is Tanezumab More Effective than a Placebo in Reducing Pain in Patients with Osteoarthritis?

Osteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT

AETNA BETTER HEALTH Prior Authorization guideline for Injectable Osteoporosis Agents

Practical Management Of Osteoporosis

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime

Prevention of Osteoporotic Hip Fracture

HIV and your Bones Osteopenia and Osteoporosis

Inflammatory rheumatic diseases

Brisbin Family Chiropractic

Clinical Practice. Presented by: Internist, Endocrinologist

Rheumatoid Arthritis. Rheumatoid Arthritis. RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling. Rheumatic Diseases

All about Osteoporosis symptoms, diagnosis, treatment

Osteoarthritis What is new? Dr Peter Cheung, Rheumatologist, NUHS

My joints ache. What is the difference between osteoporosis and osteoarthritis?

Joint Disorders. Musculoskeletal Disorders (Part B-2) Module 7 -Chapter 10. Overview Disorders of the Muscular System Disorders of the Skeletal System

Helpful information about bone health & osteoporosis Patient Resource

4 2 Osteoarthritis 1

Disclosures Fractures:

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1.

What is Osteoporosis?

The Joints are Painful & Swollen: Do I give Steroids? Dr Tom Kennedy

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Forteo (teriparatide) Prior Authorization Program Summary

Arthritis of the Knee

This Coverage Policy applies to Individual Health Insurance Marketplace benefit plans only.

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Osteoporosis: Who, What, When, Why, and How

Common Elbow Problems

Page 1. New Developments in Osteoporosis. What s New in Osteoporosis

Arthritis. What is arthritis? Who is affected? What treatment options are available?

Transcription:

Osteoporosis A systemic skeletal disease characterised by low bone mass and microarchitectural deterioration of bone tissue with subsequent increased risk of fracture. World Health Organisation

Epidemiology of Osteoporosis 20 000 fractures / year in UK Cost to NHS over 940 million Increased mortality and morbidity Early mortality with hip # Late mortality with vertebral #

Histology

Radiographic Changes

Fracture Sites Wrist risk >55y Vertebral Hip risk>60y risk>65-70

Risk factors Postmenopausal women Corticosteroids Other medical problems Inflammatory arthritis Inflammatory bowel disease Hyperthyroidism Malignancy Family history esp maternal hip #

Risk factors Lifestyle Factors Smoking Alcohol Low Body Mass Index <18 Poor diet Lack of exercise

How to Measure Bone Density DEXA scan gold standard Compares patient value to mean expected peak bone mass. Population data from white Caucasian women T score = number of standard deviations from peak bone mass

DEXA and Osteoporosis T score between 0 and -1.0 NORMAL T score between -1.0 and -2.5 OSTEOPENIA Tscore less than -2.5 OSTEOPOROSIS

Is a DEXA compulsory to diagnose osteoporosis?

Case History 1 A 55 year old woman. Postmenopausal Colles # T score Hip -1.4 T score L spine -1.0 Otherwise well Not on other treatment

Case History 2 65 year old woman Postmenopausal Vertebral # Rheumatoid arthritis Prednisolone 10mg T score Hip -3.0 T score L spine -3.0

Case History 3 35 year old woman Premenopausal Family history No # T score Hip -1.5 T score L spine -2.0 Otherwise well

Case History 4 35 year old woman Hysterectomy and oophorectomy 10 y ago On HRT only last 2 years No # T score hip -3.0 T score L spine -3.5

Treatment Aim to reduce fracture risk Increasing BMD as measured by DEXA may not equate totally with this!

Non-Pharmacological Lifestyle alterations Smoking Alcohol Diet weight bearing exercise Fall reduction

Calcium/Vitamin D Should be given to all if intake thought to be low. Poor use as a sole agent apart from frail elderly.? treating subclinical osteomalacia

HRT Most evidence from observational data 1 RCT showed effect on non-vertebral # risk reduction. Beneficial effect ceases on stopping Rx Worries about breast cancer/cvs mortality

Alendronate Prevention and Rx/SIOP 10mg daily Fracture Intervention Trial Increases in BMD Reduction in vertebral # Problems with GI side effects New equivalent weekly preparation

Risedronate Prevention/Rx/SIOP 5mg OD RR of new vert # 0.35 after 1y, 0.59 at 3y RR of non-vert # at 3 y 0.6 Significant increases in BMD Placebo incidence of GI side effects

Raloxifene Prevention/Rx BMD increases 2-3% RR of vert # 0.7 No effect on hip# risk? reduced risk of bresat cancer Thromboembolism risk

How to treat Case 1? Lifestyle advice Ca/Vit D Raloxifene

How to treat Case 2 Lifestyle Ca/Vit D Bisphosphonate Risedronate if fast risk reduction preferrred prednisolone to lowest possible dose

How to treat Case 3 Lifestyle Ca/Vit D NO BISPHOSPHONATES

How to treat Case 4 Lifestyle Ca/Vit D Calcitriol? Continue HRT? Bisphosphonate? No uterus/ovaries Young absolute # risk low

Conclusion Osteoporosis a major health problem Ageing population Better patient awareness Better treatments Guidelines www.rcplondon.ac.uk

Tratment Options Premenopausal Lifestyle ca/vit D?bisphosphonates Postmenopausal?HRT for symptoms SERM for 5-10 years then bisphosphonate

Osteoarthritis

Introduction Chronic degenerative disorder loss of articular cartilage most prevalent disease in society In England and Wales, 1.3-1.75M people affected

Features Over 50 pain and stiffness swelling disability

Risk factors Age Trauma Occupation esp kneeling, bending gender obesity men>women under 50 women>men over 50

Case 1 65 year old man symptomatic knee OA on aspirin no response to paracetamol

Management Non-drug Drugs exercise weigt loss mechanical aids simple analgesia NSAIDs? COX-2 drugs

Management Intra-articular steroids Hyaluronic acid derivatives Glucosamine sulphate Surgery analgesic?disease modifier arthrodesis arthroplasty washouts

Case 1 25 year old legal secretary 1 year worsening pain both arms and pins and needles in hands difficult to work anxious Little to find on examination Neuro normal Slight lateral epicondyle tenderness Neck ok. trapezius tender

The workplace and upper limb pain Numbness/tingling in the hands very common. Prevalence ~33% Several causes Cervical root entrapment peripheral nerve entrapment WORK!

History Symptoms relation to work relation to rest eg holidays psychosocial issues

Workplace ergonomics Sensible advice, but little/no evidence! Details: apple.com/about/ergonomics/index.html

Examination Neck Neurological examination Tests for adverse neural tension Carpal tunnel Posture risk if repeated finger/wrist movements bending/straightening of elbow carrying>5kg in one hand

Solutions Workplace ergonomics Treat carpal tunnel Posture advice Physio for adverse neural tension restrict time at desk Exercise!? C Spine X Ray to exclude pathology